Formerly known as Newborn Metabolic Screening (NMS) Program, the Alberta Newborn Screening Program (ANSP) is about health care providers working together with parents to screen for certain treatable conditions.
* Population based screening programs offer a screening test(s) to all individuals in a defined population with agreed upon policies, protocols, quality management, monitoring and evaluation methods.
The newborn blood spot screening pathway makes sure all screened infants who may have one of the treatable conditions get clinical assessment, diagnostic testing and early treatment if needed. It consists of the following steps:
Timely screening helps find infants with conditions that can be treated early, when the treatment can help the most. Without timely screening and intervention, infants with treatable conditions may suffer irreversible health problems and possibly death soon after birth.
Early detection and treatment of screened conditions can make the difference between healthy development and lifelong impairment.
Support for blood spot collection staff such as public health nursing services, postpartum, neonatal intensive care units, FN communities, midwives and Alberta Precision Laboratories (APL).
Support for physicians and midwives to understand the treatable conditions screened for by the program.